Bavarian Nordic (OTCPK:BVNRY) has received FDA approval for its vaccine Vimkunya for the prevention of chikungunya. The virus-like particle, or VLP, vaccine is approved for people aged 12 and older.
Bavarian Nordic’s chikungunya vaccine Vimkunya is one step closer to being available in Europe after having secured an ...
La Agencia Europea del Medicamento (EMA, por sus siglas en inglés) ha recomendado conceder la autorización de comercialización a la vacuna 'Vimkunya', destinada a proteger frente al virus de ...
The inflation rate in Germany is expected to be +2.3% in January 2025. It is measured as the change in the consumer price index (CPI) compared with the same month a year earlier. Based on the results ...
Injuries and health issues such as a chikungunya infection saw him making a pre-quarterfinal exit from the Paris Olympics, before a second round appearance Malaysia Super 1000 earlier this month ...
In fact, many of the patients who were diagnosed with Chikungunya have revealed that the joint pains continue for months after they recover from the infection. Adding about the same in the caption ...
And now, in her latest Instagram story, the diva dropped a major health update, as she revealed to have suffered from Chikungunya. Check out the glimpse here: In the glimpse that she shared ...
In comparison to the dengue cases, there was a steep increase in the total number of chikungunya and malaria cases reported in 2024. A total of 792 malaria cases (including four cases reported in ...
Las sequías, inundaciones y altas temperaturas, asociados al cambio climático, provocaron un aumento exponencial de casos de dengue en la región de las Américas, donde este año, se triplicó ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback